UK markets closed

Cara Therapeutics, Inc. (CARA)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
0.6843-0.0157 (-2.24%)
At close: 04:00PM EDT
0.6843 0.00 (0.00%)
After hours: 04:20PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts5555
Avg. Estimate-0.4-0.25-1.09-1.02
Low estimate-0.43-0.26-1.23-1.34
High estimate-0.35-0.23-0.84-0.68
Year ago EPS-0.49-0.58-2.19-1.09
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts5555
Avg. Estimate1.69M1.44M5.59M3.67M
Low estimate300k80k1.3MN/A
High estimate3.02M3.54M13.66M12.55M
Year ago sales6.17M6.93M20.97M5.59M
Sales growth (year/est)-72.60%-79.20%-73.30%-34.30%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-0.52-0.54-0.52-0.41
Actual EPS-0.49-0.58-0.52-0.59
Difference0.03-0.040-0.18
Surprise %5.80%-7.40%0.00%-43.90%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-0.4-0.25-1.09-1.02
7 days ago-0.4-0.25-1.09-1.02
30 days ago-0.4-0.25-1.15-1.11
60 days ago-0.42-0.31-1.26-0.94
90 days ago-0.42-0.31-1.26-0.94
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days1111
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesCARAIndustrySector(s)S&P 500
Current qtr.18.40%N/AN/AN/A
Next qtr.56.90%N/AN/AN/A
Current year50.20%N/AN/AN/A
Next year6.40%N/AN/AN/A
Next 5 years (per annum)110.70%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A